NSTL国家科技图书文献中心

1. Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database NSTL国家科技图书文献中心

Yan, Liyuan | Zheng, Guanqun - 《Expert opinion on drug safety》 - 2025,24(3) - 345～353 - 共9页

摘要：. Disproportionality* analysis revealed that the top 5 drugs by ROR* | inserts.ConclusionThrough comprehensive analysis* of the FAERS database* | BackgroundThis investigation aims to identify | and evaluate the most common and critical drugs | associated with the risk of noninfectious myocarditis

关键词： Non-infectious myocarditis | FAERS | disproportionality analysis | pharmacovigilance | data mining

2. A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies NSTL国家科技图书文献中心

Balshi, Alexandra | Dempsey, John ... - 《Journal of neurology》 - 2025,272(3) - Article 223～Article 223 - 共5页

摘要： SSI-associated deaths. A pooled analysis* of all DMTs* | Background and objective People with multiple | sclerosis (PwMS) may be at an increased risk of surgical | site infections (SSIs). However, the role of specific | MS disease-modifying therapies (DMTs) in modulating

关键词： Multiple sclerosis | Surgical site infections | Disproportionality analysis

3. A Real-World Disproportionality Analysis of Histamine H2-Receptors Antagonists (Famotidine): A Pharmacovigilance Study Based on Spontaneous Reports in the FDA Adverse Event Reporting System NSTL国家科技图书文献中心

Zhang, Dongdong | Cai, Ying ... - 《Drug Development Research》 - 2025,86(1) - e70045～e70045 - 共12页

摘要： (FAERS) database. A disproportionality* analysis was* | Famotidine is an H2 receptor antagonist and is | currently used on a large scale in gastroenterology | . However, Famotidine may also cause severe toxicity to | organ systems, including the blood system, digestive

关键词： adverse event | disproportionality analysis | FAERS | Famotidine | pharmacovigilance

4. Association between glucagon-like peptide-1 agonists and risk of diabetic retinopathy: a disproportionality analysis using FDA adverse event reporting system data NSTL国家科技图书文献中心

Singh, Harmanjit | Natt, Navreet Kaur ... - 《Expert review of endocrinology & metabolism》 - 2025,20(2) - 147～152 - 共6页

摘要： disproportionality analysis was conducted using FDA Adverse Event | BackgroundGlucagon-like peptide-1 (GLP-1 | ) agonists are commonly prescribed for type 2 diabetes | mellitus (T2DM). Concerns have emerged regarding their | potential link to diabetic retinopathy (DR).MethodsTo

关键词： GLP-1 agonists | diabetic retinopathy | semaglutide | liraglutide | disproportionality analysis | FAERS

5. Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System NSTL国家科技图书文献中心

Barbieri, Maria Anto... | Russo, Giulia ... - 《European journal of clinical pharmacology》 - 2025,81(5) - 755～770 - 共16页

摘要： System (FAERS) database. Descriptive analysis* was* | followed by disproportionality* analyses first comparing* | subsequently conducting a sensitivity analysis* against other* | = 3338; 50.8%) patients. Disproportionality* analyses* | IntroductionMonoclonal antibodies (mAbs) have

关键词： Cardiovascular toxicity | Disproportionality analysis | FAERS | Monoclonal antibodies | Multiple myeloma | Respiratory toxicity

6. Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022 NSTL国家科技图书文献中心

Mikaeili, Bahar | Alqahtani, Zuhair A.... - 《Clinical rheumatology》 - 2025,44(4) - 1467～1474 - 共8页

摘要： retrospective disproportionality* analysis was performed using* | Introduction/objectiveJanus kinase (JAK | ) inhibitors have expanded treatment options for rheumatoid | arthritis (RA), particularly for patients unresponsive to | traditional disease-modifying antirheumatic drugs (DMARDs

关键词： Adverse events | Disproportionality analysis | FAERS | Janus kinase inhibitors | Rheumatoid arthritis | Safety

7. Disproportionality analysis of amenamevir-induced encephalopathy using the Japanese adverse drug event report database NSTL国家科技图书文献中心

Yamada, Tomoyuki | Ogawa, Taku ... - 《Journal of infection and chemotherapy》 - 2025,31(1) - 102519～102519 - 共6页

摘要：-induced encephalopathy via disproportionality analysis | /delirium." Disproportionality* analysis was used to* | encephalopathy in these patients was 3 days. Disproportionality | ). Furthermore, multivariable logistic regression analysis | Introduction: Anti-herpesvirus drug-induced

关键词： Adverse event | Amenamevir | Encephalopathy | Pharmacovigilance

8. Post-marketing safety surveillance of ado-trastuzumab emtansine: a real-world data retrospective cohort study using disproportionality analysis NSTL国家科技图书文献中心

Chen, Endong | Gan, Yaowei ... - 《Expert opinion on drug safety》 - 2025,24(5) - 565～576 - 共12页

摘要： significant disproportionality* preferred terms (PTs) were* | characteristics.ConclusionThis analysis* offers the most comprehensive overview* | BackgroundAdo-trastuzumab emtansine (T-DM1) is | prescribed for HER2-positive, metastatic breast cancer or | early breast cancer after neoadjuvant therapy

关键词： FAERS, US food and drug administration adverse events reporting system | HER2-positive breast cancer | ado-trastuzumab emtansine | disproportionality analysis | adverse events | thrombocytopenia | hemorrhage

9. Suicidal behaviour and CFTR modulators: A case series and WHO database disproportionality analysis NSTL国家科技图书文献中心

Nidegger, Ines | Macey, Julie ... - 《Journal of cystic fibrosis》 - 2025,24(1) - 33～39 - 共7页

摘要： disproportionality analysis was conducted using spontaneous reports | Background: A highly effective therapy | involving elexacaftor, tezacaftor, and ivacaftor (ETI) for | cystic fibrosis (CF) patients has recently raised | safety concerns regarding potential psychiatric

关键词： Drug-related side effects and adverse reactions | Cystic fibrosis | Suicide | Attempted | Psychiatry | Pharmacovigilance | Epidemiology

10. Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database NSTL国家科技图书文献中心

Xue, Xiangzhong | Qian, Jingjing - 《Expert opinion on drug safety》 - 2025,24(1) - 59～68 - 共10页

摘要： computed to detect reporting disproportionality* in* | Background: By 31 December 2022, the United | States Food and Drug Administration (FDA) has approved | 12 biosimilar monoclonal antibody cancer treatments | . This study detected disproportionate adverse event

关键词： Biological monoclonal antibody | biosimilars | bevacizumab | trastuzumab | rituximab | adverse events | disproportionality analysis | pharmacovigilance

关键词： Non-infectious myocarditis | FAERS | disproportionality analysis | pharmacovigilance | data mining

摘要： SSI-associated deaths. A pooled analysis of all DMTs | Background and objective People with multiple | sclerosis (PwMS) may be at an increased risk of surgical | site infections (SSIs). However, the role of specific | MS disease-modifying therapies (DMTs) in modulating